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Cardiovascular disease and mortality in a community-based cohort accounting for 50% of all deaths in patients on dialysis
with mild renal insufficiency. and in recipients of renal transplants [1]. Mortality from
Background. Little is known about the prevalence of cardio- CVD in these patients is approximately 9% per year,vascular disease (CVD) and associated risk factors in individu-
which is about 30 times the risk in the general populationals with mild renal insufficiency (RI). Furthermore, the long-
[2]. The excess risk of CVD in ESRD is due in part toterm outcomes associated with mild RI in the community have
not been described. a higher prevalence of established arteriosclerotic risk
Methods. Serum creatinine (SCr) was measured in 6233 adult factors, including older age, hypertension, diabetes, dys-
participants of the Framingham Heart Study (mean age 54 years, lipidemia, and physical inactivity [3–5]. Unique renal-54% women). Mild RI was defined as SCr 136 to 265 mmol/liter related risk factors, including hemodynamic and meta-(1.5 to 3.0 mg/dl) in men and 120 to 265 mmol/liter (1.4 to 3.0
bolic factors characteristic of chronic renal disease, alsomg/dl) in women. The lower limits for mild RI were defined
by the sex-specific 95th percentile SCr values in a healthy sub- likely contribute to this excess CVD risk [5–8].
group of our sample. The upper limit for mild RI was chosen In contrast, CVD risk and prevalence in patients with
to exclude those subjects with more advanced renal failure. Cox less severe renal impairment are poorly described, partlyproportional hazards analyses were used to determine the rela-
because this population is less captive than those patientstionship of baseline RI to CVD and all-cause mortality.
requiring dialysis or transplantation management. Ironi-Results. At baseline, 8.7% of men (N 5 246) and 8.0% of
women (N 5 270) had mild RI. Nineteen percent of the subjects cally, it is in this population that CVD preventative strat-
with mild RI had prevalent CVD. During 15 years of follow- egies are likely to have their greatest benefit on CVD
up, there were 1000 CVD events and 1406 deaths. In women, risk. The general lack of information on CVD risk, mor-mild RI was not associated with increased risk for CVD events
bidity, and mortality in patients with RI was highlighted[hazards ratio (HR) 1.04, 95% CI, 0.79 to 1.37] or all-cause
in a recent report from a National Kidney Foundationmortality (HR 1.08, 95% CI, 0.87 to 1.34). In men, mild RI
showed no significant associations with CVD events (HR 1.17, Task Force on CVD [5].
95% CI, 0.88 to 1.57), but it was associated with all-cause We now describe a cohort of men and women with
mortality in age-adjusted (HR 1.42, 95% CI, 1.12 to 1.79) and
mild RI who were examined prospectively for 15 years.multivariable adjusted (HR 1.31, 95% CI, 1.02 to 1.67) analyses.
The objectives of this study were (a) to determine theConclusion. Mild RI in the community is common and is
associated with a high prevalence of CVD. The association of prevalence of CVD and traditional CVD risk factors in
RI with risk for adverse outcomes is strongly related to coexist- subjects with mild RI and (b) to describe the relationships
ing CVD and CVD risk factors. of mild RI to incident CVD events and all-cause mortality.
METHODSCardiovascular disease (CVD) is the major cause of
death in patients with end-stage renal disease (ESRD), Study sample
The Framingham Heart Study is a continuing study
that started in 1948 when 5209 residents of FraminghamKey words: serum creatinine, renal failure, Framingham Heart Study,
mortality. (MA, USA), aged 28 to 62 years, were enrolled in a
prospective epidemiological cohort study to identify traitsReceived for publication April 13, 1999
or characteristics predisposing to the development ofand in revised form July 12, 1999
Accepted for publication July 19, 1999 CVD [9, 10]. Participants are assessed every two years
by medical histories, physical examinations, and selected 1999 by the International Society of Nephrology
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laboratory tests. In 1971, 5124 of the original partici- according to previously published criteria [18] by a panel
of three physicians after review of Framingham Heartpants’ offspring and spouses of offspring were enrolled
and followed up every four years [11]. Study and outside hospital and physician records.
All original subjects of the Framingham Heart Study
Analysis and statistical methodswho participated in the 15th biennial examination (1977
through 1979, N 5 2632) and adult participants in the Separate analyses were performed for men and women.
Subjects were divided into two categories according tosecond examination of the Framingham Offspring Study
(1979–1983; N 5 3853) were eligible for this investiga- baseline SCr: normal versus mild RI. Prevalence rates of
traditional CVD risk factors for both categories weretion. Blood samples for serum creatinine (SCr) were not
obtained in 247 individuals. Three subjects were excluded compared using the chi-square test. Crude event rates
were calculated for both categories. Age-adjusted sur-for missing covariates or follow-up data, and an addi-
tional seven participants were excluded because of more vival estimates were determined using Cox proportional
hazards analyses [19]. Cox regression models were alsoadvanced renal failure (discussed later in this article).
The remaining 6228 participants were followed prospec- used to examine the relationships of mild RI, with sub-
jects with normal SCr values as the reference category,tively until 1994.
to incident CVD events and all-cause mortality. For com-
Baseline measurements and definitions parative purposes, hazard ratios were calculated using
no adjustment. For inferential purposes, hazard ratiosMedical histories and physical examinations were ob-
tained every two to four years. Systolic and diastolic were calculated with adjustment for age only and with
adjustment for age and other clinical variables associatedblood pressures were obtained twice in the left arm of
seated subjects by the examining physician using a mer- with CVD and mortality. The covariates in the fully
adjusted model included BMI (kg/m2), diabetes mellituscury column sphygmomanometer positioned near eye
level. The average of the two readings was used for each (yes vs. no), systolic blood pressure (mm Hg), use of
antihypertensive medications (yes vs. no), total choles-blood pressure variable. The diagnosis of hypertension
was based on JNC VI criteria [12] as a blood pressure terol (mmol/liter), HDL cholesterol (mmol/liter), smok-
ing status (yes vs. no), prevalent CVD (yes vs. no), use$140 mm Hg systolic, $90 mm Hg diastolic, or the cur-
rent use of anti-hypertensive drug treatment. Height and of cardiac medications (yes vs. no), and echocardiogram
left ventricular hypertrophy (LVH; yes vs. no).weight were measured at each examination, and body
mass index (BMI) was calculated as the weight in kilo- All analyses were performed on a SUN Ultrasparc
using SAS (SAS Institute, Cary, NC, USA) software [20].grams divided by the square of the height in meters.
Those who reported regularly smoking at least one ciga- A two-sided P value of less than 0.05 was the criterion for
statistical significance.rette per day during the year before the examination
were classified as current smokers.
Diabetes was defined on the basis of a nonfasting blood
RESULTS
glucose level $11.1 mmol/liter, a fasting blood glucose
Baseline subject characteristicslevel $7.8 mmol/liter, or the use of insulin or an oral
hypoglycemic agent. SCr values were determined by either Criteria for mild RI were fulfilled in 8.7% (N 5 246)
of men and 8.0% (N 5 270) of women (Table 1). Inthe autoanalyzer technique [13, 14] or the creatinine imo-
dohydrolase assay [15]. Cholesterol was determined ac- these subjects, mean SCr levels were 147 mmol/liter in
men and 137 mmol/liter in women. Women with mild RIcording to the Abell–Kendall method [16]. High-density
lipoprotein (HDL) cholesterol was measured after pre- were older than their male counterparts (66.4 vs. 54.4
years). CVD was present at baseline in 18% of men andcipitation of other lipoproteins with heparin maganese.
We defined mild RI as a SCr value of 136 to 265 mmol/ 20% of women with mild RI. LVH was three to four
times more prevalent in subjects with RI compared withliter in men and 120 to 265 mmol/liter in women. The
lower limits of SCr were defined by the sex-specific 95th subjects with normal SCr values.
Figures 1A (men) and 1B (women) illustrate the prev-percentile SCr values in a healthy subgroup of our sample
[17]. The upper limit of SCr used in this definition was alence of traditional CVD risk factors according to renal
function status. Among men with mild RI, hypertensionchosen to exclude those subjects (N 5 7) with more
advanced renal failure. was present in greater than one third, and diabetes oc-
curred in 10.6%. Unfavorable total and HDL cholesterolThe diagnosis of CVD included coronary heart disease
(coronary insufficiency, recognized myocardial infarc- levels were also more common in those men with mild
RI compared with those with normal SCr levels. Amongtion, coronary heart disease death), congestive heart fail-
ure (CHF), and ischemic stroke. The Framingham defi- women with mild RI, hypertension was present in 39.3%
and diabetes in 9.2%. The prevalence of unfavorablenitions of CVD and related events have been described
elsewhere [18]. The outcome events were determined total and HDL cholesterol levels was significantly higher
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Table 1. Baseline clinical characteristics of subjects by renal function category
Normal serum creatinine Mild renal insufficiency
Men Women Men Women
(N 5 2591) (N 5 3116) (N 5 246) (N 5 270)
Age years 53.1614.5 54.3 615.3 54.4615.8 66.4 613.3
BMI kg/m2 26.663.6 25.2 64.8 27.263.7 25.6 64.8
Serum creatinine mmol/liter 102618 88 617 147615 137 617
Creatinine clearancea ml/min 88629 68 625 60618 37 611
Systolic blood pressure mm Hg 130617 126 620 131619 135 622
Diastolic blood pressure mm Hg 80610 75 69 80611 75 611
Antihypertensive medications % 16.8 20.4 29.7 40.4
Total cholesterol mmol/liter 5.4160.98 5.60 61.15 5.5061.03 6.08 61.19
HDL cholesterol mmol/liter 1.1260.31 1.39 60.37 1.0760.30 1.34 60.38
Triglycerides mmol/liter 1.6960.94 1.24 60.67 2.0461.09 1.41 60.81
Diabetes mellitus % 5.8 3.9 10.6 9.2
Current smoker % 30.9 31.3 26.0 19.3
Prevalent CVD % 13.9 9.3 17.9 20.4
Prevalent CHD % 10.0 6.0 14.2 16.3
Prevalent CHF % 0.8 1.5 2.0 2.6
ECG LVH % 0.9 0.8 2.9 3.7
Cardiac medications % 7.3 7.0 11.8 18.2
Values indicate mean 6 standard deviation, or percentage. Abbreviations are: BMI, body mass index; HDL, high density lipoprotein; CVD, cardiovascular disease;
CHD, coronary heart disease; CHF, congestive heart failure; ECG LVH, echocardiogram left ventricular hypertrophy.
a Calculated using Cockcroft-Gault formula [29]
in women with mild RI compared with those with normal CVD was highly prevalent (20%), and traditional CVD
SCr levels. Current smoking was less prevalent in both risk factors were more common in subjects with RI.
men and women with mild RI compared with those sub- During 15 years of follow-up, the presence of baseline
jects with normal SCr levels. RI was associated with a 31% increase in risk for death
in men after adjusting for baseline covariates. When we
Mild renal insufficiency and outcome events
accounted for age and other risk factors, women with
The mean follow-up was 11.0 years in men and 11.6 RI were no more likely to experience adverse CVD
years in women (Table 2 and Figs. 2 and 3). In men, events or death than women with normal SCr levels.
there were 544 incident CVD events and 709 deaths. To our knowledge, this study is the first to characterize
Three deaths were secondary to renal failure. In women, CVD risk in patients with mild RI in the community.
there were 456 CVD events and 697 deaths; 7 of these The prevalence of CVD and the risk factor burden in
deaths were attributed to renal disease.
these subjects were impressive, partially because manyIn men, mild RI was not associated with incident CVD
traditional CVD risk factors are themselves risk factorsevents, but crude mortality rates were higher in those
for renal failure. For example, greater than one third ofsubjects with RI (33.3 vs. 27.5 per thousand person-
men and women were hypertensive, and nearly 10%years). A statistically significant difference in age-
were diabetic. Furthermore, 42% of women had hyper-adjusted survival was found between the two groups
cholesterolemia, and nearly 30% of men had HDL cho-(P 5 0.003; Fig. 3). In multivariable adjusted Cox anal-
lesterol levels of less than 0.9 mmol/liter.yses, mild RI remained associated with all-cause mortal-
It has been clearly established that patients at the farity [hazards ratio (HR) 1.31, 95% CI, 1.02 to 1.67).
end of the RI spectrum, those starting renal replacementIn women, crude event rates for CVD and all-cause
therapy, have a very high prevalence of CVD, with mostmortality were higher in the RI group in comparison to
those with normal SCr values (25.6 vs. 11.0 per thousand estimates exceeding 40% [2]. We have now demon-
person-years for incident CVD and 39.5 vs. 17.6 per strated that CVD prevalence is increased even in subjects
thousand person years for all-cause mortality). These with less severe renal impairment. It is clear that any
associations were no longer statistically significant after attempt to reduce the burden of CVD in the ESRD
age adjustment (Figs. 2 and 3). Multivariable adjustment population must include aggressive management of tra-
further reduced the hazards associated with mild RI (HR ditional CVD risk factors very early in the course of
1.04, 95% CI, 0.79 to 1.37 for incident CVD, and HR renal disease.
1.08, 95% CI, 0.87 to 1.34 for all-cause mortality). The lack of association between baseline RI and inci-
dent CVD events in this study clarifies the relationship
DISCUSSION between renal impairment and vascular disease. It is
generally accepted that ESRD is associated with adverseIn this community-based sample of 6223 adults, 9%
of men and 8% of women were found to have mild RI. CVD outcomes, partially because of the high prevalence
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Fig. 1. Percent prevalence of traditional
cardiovascular disease (CVD) risk factors by
category of renal function in (A) men and
(B) women. Symbols are: ( ) normal serum
creatinine; (j) mild renal insufficiency.
*P , 0.05; **P , 0.01; †P , 0.0001.
Table 2. Risk of cardiovascular disease (CVD) and all-cause mortality by renal function category
At risk Events Hazards ratios (95% CI)
N Ratea Unadjusted Age adjusted Fully adjustedb
Cardiovascular disease
Men
Normal serum creatinine 2591 494 18.5 1 1 1
Mild renal insufficiency 246 50 21.3 1.17 (0.88–1.57) 1.17 (0.88–1.57) 1.06 (0.79–1.43)
Women
Normal serum creatinine 3116 385 11.0 1 1 1
Mild renal insufficiency 270 71 25.6 2.19 (1.70–2.83) 1.16 (0.90–1.50) 1.04 (0.79–1.37)
All-cause mortality
Men
Normal serum creatinine 2591 627 27.5 1 1 1
Mild renal insufficiency 246 82 33.3 1.54 (1.22–1.94) 1.42 (1.12–1.79) 1.31 (1.02–1.67)
Women
Normal serum creatinine 3116 581 17.6 1 1 1
Mild renal insufficiency 270 116 39.5 2.25 (1.84–2.75) 1.14 (0.93–1.40) 1.08 (0.87–1.34)
a Per thousand person-years
b Adjusted for age, BMI, systolic blood pressure, hypertension treatment, diabetes, smoking, total cholesterol, HDL cholesterol, prevalent CVD, cardiac medications,
and ECG LVH
of established CVD risk factors, but also because of ulation. With the exception of age, the authors were
unable to adjust for other risk factors [21]. Other obser-hemodynamic and metabolic risk factors characteristic
of this population [5–8]. However, CVD risk associated vational studies have been limited by select populations,
such as middle-aged men [22] or post-myocardial in-with less severe degrees of renal impairment is poorly
described. In a 10-year study of 147 predialysis patients farction (MI) patients with hypercholesterolemia [23].
The association of elevated SCr with mortality has beenreferred to a nephrology clinic, Jungers et al reported
a threefold increase in myocardial infarction incidence reported in several other studies [22–25], including the
Cardiovascular Health Study in which baseline SCr valueswhen compared with rates from the French general pop-
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Fig. 2. Age-adjusted, cardiovascular disease
(CVD) event-free survival in men and women
by category of renal function. Symbols are:
(———) normal renal function; (– – – –) mild
renal insufficiency.
Fig. 3. Age-adjusted survival probability in
men and women by category of renal function.
Symbols are: (———) normal renal function;
(– – – –) mild renal insufficiency.
greater than 150 mmol/liter were associated with a 70% Several potential limitations should be considered in
the interpretation of this study’s results. First, the studyincrease in risk for all-cause mortality in older men and
women who were followed for five years. The magnitude sample was overwhelmingly Caucasian. The prevalence
of mild RI in this study may underestimate the trueof this risk was similar to that associated with baseline
CHF and mortality [26]. Consistent with our findings, few prevalence in African American or Native American
subjects in whom prevalent ESRD rates are three to fourdeaths were attributed to renal disease in those reports
detailing the causes of death. The mechanism responsible times higher than Caucasian Americans [27]. On the
other hand, CVD deaths account for similar proportionsfor the association between elevated SCr and all-cause
mortality is incompletely understood and is likely multi- of deaths among blacks and whites on dialysis [1].
Second, SCr was used as the marker for impaired renalfactorial.
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